APIMEDS PHARMACEUTICALS US I (APUS) Technical Analysis
NYSEARCA:APUS • US03771D1028
Taking everything into account, APUS scores 0 out of 10 in our technical rating. APUS's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
- 100% of all other stocks performed better in the past year than APUS.
- APUS is part of the Biotechnology industry. There are 519 other stocks in this industry, of which 93% are performing better than APUS.
- In the last month APUS has a been trading in the 0.95 - 1.75 range, which is quite wide. It is currently trading near the high of this range.
- Considerably lower volume is observed in the last couple of days.
Although the technical rating is bad, APUS does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period. We notice that large players showed an interest for APUS in the last couple of days, which is a good sign.
- Behavior of large players is measured by the Effective Volume indicator. This indicator inspects the 1 minute timeframe looking for high volume transactions.
More info and screens
1.28
We found 2 important support areas.
- A support zone ranging from 1.32 to 1.36. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- Support @1.29 from a horizontal line in the daily time frame.
When analyzing the resistance we notice 2 important areas.
- Resistance @1.46 from a trend line in the weekly time frame.
- A resistance zone ranging from 1.56 to 1.57. This zone is formed by a combination of multiple trend lines and important moving averages in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for APUS is down. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for APUS is neutral. |
| ChartMill Relative Strength | 0 | NEGATIVE | APUS has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | MIXED | The current price of APUS is above a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of APUS is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of APUS is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 45.81 | NEUTRAL | The RSI value for APUS is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.02 | POSITIVE | The MACD value suggests APUS has a positive trend. |
| Stochastics (14,3) | 32.65 | NEUTRAL | The Stochastics value for APUS is a neutral value. |
| Average True Range in percent/ATR (20) | 12.47 | HIGH VOLATILITY | The high ATR as a percentage value for APUS suggests high volalility. |
| Average Directional Index/ADX (14) | 15.48 | NEGATIVE | The low ADX value for APUS suggests a weak or negative trend. |
APUS Technicals: Chart, Performance Metrics, Trend & Indicators
NYSEARCA:APUS (3/12/2026, 2:15:21 PM)
1.42
+0.08 (+5.97%)
APIMEDS PHARMACEUTICALS US I / APUS FAQ
What is the ChartMill technical rating of APIMEDS PHARMACEUTICALS US I (APUS) stock?
ChartMill assigns a technical rating of 0 / 10 to APUS.
What is the current trend direction of APIMEDS PHARMACEUTICALS US I (APUS) stock?
The current trend direction for APIMEDS PHARMACEUTICALS US I (APUS) is Bearish.
What is the RSI signal for APUS stock?
APIMEDS PHARMACEUTICALS US I (APUS) has an RSI value of 45.8103. This indicates that the stock is currently neutral.
Can you provide the short term momentum for APIMEDS PHARMACEUTICALS US I?
The short term momentum for APIMEDS PHARMACEUTICALS US I (APUS) is neutral.